A Multi-Center Phase I Study of Intravenous Deforolimus (AP23573, MK-8669) Administered QDX5 Every Other Week in Pediatric Patients With Advanced Solid Tumors (8669-028)(COMPLETED)
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Solid Tumors
Related studies linked through entity extraction aliases.
Target Dosing of Docetaxel Through Pharmacokinetic/Pharmacodynamic Optimisation of the First Chemotherapeutic Cycle
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Phase I Study on Monoclonal Antibody TB-403 Directed Against PlGF in Patients With Solid Tumours
- Status
- COMPLETED
- Phase
- PHASE1
Study of CBP501 + Pemetrexed + Cisplatin on MPM (Phase I/II)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Study of Capecitabine In Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel
- Status
- COMPLETED
- Phase
- PHASE2
Study of STA-9090, Administered Twice-Weekly in Patients With Solid Tumors
- Status
- UNKNOWN
- Phase
- PHASE1
Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
A Phase I Study of BIIB015 in Relapsed/Refractory Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Abraxane Weekly and Three Weekly Schedule With Vandetanib
- Status
- COMPLETED
- Phase
- PHASE1
Safety Study of ASONEP (Sonepcizumab/LT1009) to Treat Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Study Of Advanced Gastrointestinal Malignancies And Other Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Evaluation of KX2-391 in Patients With Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Panitumumab in Children With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function
- Status
- COMPLETED
- Phase
- PHASE1
A Dose Escalation Study of Adavosertib (MK-1775) in Combination With Either Gemcitabine, Cisplatin, or Carboplatin in Adults With Advanced Solid Tumors (MK-1775-001)
- Status
- COMPLETED
- Phase
- PHASE1
Genasense as a 2-hour Intravenous Infusion in Subjects With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Phase I Study of MT110 in Lung Cancer (Adenocarcinoma and Small Cell), Gastric Cancer or Adenocarcinoma of the Gastro-Esophageal Junction, Colorectal Cancer, Breast Cancer, Hormone-Refractory Prostate Cancer, and Ovarian Cancer
- Status
- COMPLETED
- Phase
- PHASE1
ABI-009 Trial in Patients With Advanced Non-hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Spirituality/Religiosity in Patients and Caregivers
- Status
- COMPLETED
- Phase
- N/A